Exchange: NASDAQ·Updated 06:49 AM EDT
MDCX logo

MDCX Medicus Pharma Ltd

$0.1582
$0.0012
(0.76%)
Pre-Market
Prev Close $0.157
Reported EarningsAug 12
Mkt Cap$10.17M
Vol4,552.00

About MDCX

Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.
29

Bearish Sentiment

How do you feel about MDCX?

BullishStockCatcher
Tuesday Top Bullish List 💹 $MDCX ✅ Huge upside potential news licensing deal with Pfizer worth $1B for antibody drug conjugate 💹 $ATER ✅ High volume Friday during business hours and Top after hours volume Something cooking /One of the top all time runners in the past 💹 $ISPC ✅ Friday Top after hours gainers low float with AI acquisition news Can be Tuesday top runner with volume 💹 $DVLT ✅ Datavault AI to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference call on the 10th Can reverse hard before the conference date 💹 $GPRO ✅ Continuation uptrend Can squeeze again next week 💹 Tuesday very Bullish 💹 🔔 Home of bullish alerts 💹
2
14
Moneyindabanknow
$MDCX it’s going to be like IBIO in the day. it was like .20+ and rocketed up to $3+ one afternoon due to short squeeze.
1
6
ChartDemon
$MDCX after doing some deep dive research, this is bad, i sold equal hours ago, they are going into debt against pfizer by taking chances with pfizer meds patent by allowing them to change it for the better version which is risky without legal issue since pfizer agreed on it, but if successful and FDA MDCX can be worth 100m-1B instantly, which time will tell, also they are paying pfizer 10m + upfront and another 15m by next year, this is why i am out. This is negative for me. This is also why the stock fell today.
1
6
Lyn30
$MDCX IMO This stock has big potential. I like this stock . Big price target and few recent developments r attractive. IMO high risk high reward play . I will be holding for long to see if it reach my desired price .
7
izjustlooking
$MDCX Because Gorlin Syndrome is a rare disease with a massive unmet medical need, the FDA cleared a Phase 2b trial (SKNJCT-005) designed to serve as a registrational study. Direct Path to Approval: A registrational or "NDA-enabling" trial means that if the Phase 2b data is strong and meets safety and efficacy goals, Medicus Pharma can use it to apply directly for FDA approval (New Drug Application). This allows them to effectively bypass a standard, lengthy Phase 3 trial
7
Lyn30
$MDCX Penny stock always risky bet imo But always there is a calculation behind the story whether company wants or no. My bet 1+ and I have my own reasoning I always count risk VS reward , potential gain vs loss
7
Duskfall
$MDCX The current market capitalization of approximately $11 million is very low relative to what the company currently has in its pipeline. Keep👀📈✅ 🔥🔥🔥🔥🔥 $OCGN $PFE $MRNA $SPY
1
4
spivak1976
$MDCX I double my position and smacked the ask at .17. It lowered my average a bit and showed some bull horns. Bring it.
6
pakman197
$MDCX Damn.. they sure make it hard to be a long when put out two great pieces of News and each time there is no real modest upward movement, during normal trading hours, but I will continue to hold LONG.. has to be worth more than 17 cents.. (Ive seen some Analysts call for 3-4$ s plus I think might been based on some milestones but still)
6
Lyn30
$MDCX It’s a big news Instead off going to the moon rocket fell down It should go minimum 1+ with the news imo
1
3
Zackpedia
$MDCX Paid 10M! Down to .15, low on cash now and needs to raise capital by issuing and selling millions of shares.
1
3
Dl71174
$MDCX something is so really messed up with this Market great news and it's actually at the 52 week year low
1
2
focafoca99
$MDCX terminated its Standby Equity Purchase Agreement with Yorkville, ending a $15M financing option.
4
Cheeno418
$MDCX is extremely beaten down and technically oversold. The Pfizer and Phase 2 recent catalyst gives this a legitimate fundamental reason for a rebound. Starting a small position here.
4
FawkTrading
$MDCX I just did a lil digging and I’m starting feel even better about this. Holding. Just cancelled most of my limit sells. 1$ + cause just maybe I got it right for once
4
Zokbar
$MDCX i’m not a bear or short. But it’s important to know it’s a billion dollar deal for PFIZER not Medicus. Medicus is paying $12M up front, $15M in a year and then PFE gets up to $1B in milestone payments. Pfe only paid Mdcx $2M up front to help them start production. This is not, I repeat NOT, a “billion dollar deal” for MDCX. It’s a long term gamble purchasing a product from Pfizer, where both will be involved in the production.
1
1
KimberleyAnn
$MDCX $PFE mdcx, took a handful on this news; and watching walf’s calls over the summer have been pretty 🥵
4
johnlesser
$MDCX Normally linking a tiny biotech with a giant like Pfizer the thing doubles or triples immediately, who knows maybe delayed reaction 
4
Cullousus
$MDCX I figured this news would send it seems like dilution occured instead to pay for it...
1
1
Iskanderz
$MDCX like 7-8 positive catalyst for this year + 4-5 incoming and stock still tanking ?? 🤭 could this be a BIG BIG bear trap ?? i trust their management and ex CEO from TEVA tells me i m on the right spot ..add more with every occasion 🫡 GL 🚀🚀🚀🚀🚀
3

Advertisement|Remove ads.